Literature DB >> 7104142

Cardiac dose-response relationships of oral and intravenous pindolol.

S G Carruthers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7104142      PMCID： PMC1402156          DOI： 10.1111/j.1365-2125.1982.tb01910.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

2.  Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.

Authors:  J Meier; E Nüesch
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.

Authors:  H J Waal-Manning; F O Simpson
Journal:  N Z Med J       Date:  1974-08-28

4.  Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate.

Authors:  S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

5.  Dose-dependent decline of pharmacologic effects of drugs with linear pharmacokinetic characteristics.

Authors:  M Gibaldi; G Levy
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

6.  Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.

Authors:  D G McDevitt; H C Brown; S G Carruthers; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

7.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

8.  Measurement of partial agonist activity of pindolol.

Authors:  S G Carruthers; Y Twum-Barima
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

9.  Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.

Authors:  G L Jennings; A Bobik; E T Fagan; P I Korner
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335
  9 in total
  8 in total

1.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.

Authors:  M F Rousseau; H Pouleur; J C Debaisieux; C Van Eyll; A A Charlier
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

3.  Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity have any influence during chronic therapy?

Authors:  R J Northcote; M B Cooke; D Ballantyne
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

4.  Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol.

Authors:  H Ihlen; S Simonsen; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors:  B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?

Authors:  B Silke; S P Verma; R C Ahuja; M Hussain; M Hafizullah; G Reynolds; G I Nelson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.

Authors:  B Silke; M A Frais; S P Verma; G Reynolds; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Contrasts between pindolol and propranolol concentration-response relationships.

Authors:  S G Carruthers; W L Pacha; W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.